← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2008Last known activity
Aug 14, 2017
Acquired by AstraZeneca on Jan 1, 2012
Timeline
1990s
- Jan 1, 1994
Ardea Biosciences— Founded
2000s
- Dec 21, 2006
IntraBiotics Pharmaceuticals— Acquired
2010s
- Jan 1, 2012
AstraZeneca— Acquired By
Drugs by trial phase (14 distinct, 38 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 1 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT03272425Lead sponsorPhase 1Aug 14, 2017
- NCT03272425Study directorPhase 1Aug 14, 2017
- NCT02888054Lead sponsorPhase 1Aug 30, 2016
- NCT02888054Study directorPhase 1Aug 30, 2016
- NCT02608710Study directorPhase 1Nov 1, 2015
- NCT02608710Lead sponsorPhase 1Nov 1, 2015
- NCT02581553Lead sponsorPhase 1Oct 1, 2015
- NCT02581553Study directorPhase 1Oct 1, 2015
- NCT02498652Study directorPhase 2Jul 1, 2015
- NCT02498652Lead sponsorPhase 2Jul 1, 2015
- NCT02448368Lead sponsorPhase 1May 1, 2015
- NCT02448368Study directorPhase 1May 1, 2015
- NCT02398448Lead sponsorPhase 1Apr 1, 2015
- NCT02398448Study directorPhase 1Apr 1, 2015
- NCT02317861CollaboratorPhase 1/Phase 2Dec 1, 2014
Details
- Founded
- San Diego, CA, US Jan 1, 1994
- Last known activity
- Aug 14, 2017
Notes
Acquired by AstraZeneca on 23 Apr 2012